• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Academic MOUs

ssLINK/UCM414998

MOU No.

Purpose

Parties

FDA Lead
Center or
Office/
Contact

Effective
Date

Expiration
Date

224-11-0024Establishes a collaborative framework between the FDA and the University of Florida through a variety of programs, including collaborative education and research. University of FloridaCDER
Ryan Chatman
(301) 796-2106
09-21-201109-20-2016

225-02-8001

Establishes terms of collaboration between FDA and UMD to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.University of MDOC
Eileen Parish
(301) 796-8522

09-04-2002

Indefinite

225-03-6000

Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.University of HoustonCDRH
Michelle Chenault
(240) 276-3815

03-29-2003

Indefinite

225-03-8002

Establishes terms of collaboration between FDA and VA Polytechnic Institute to support shared interest in scientific progress through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.VA Polytechnic
Institute

OC
Eileen Parish

(301) 796-8522

03-13-2003

Indefinite

225-03-8003

Establishes terms of collaboration between FDA and Howard University to support shared interest in scientific progress affecting human and animal health and medicine through a variety of programs such as sabbaticals, postdoctoral fellowships, and student internships.Howard UniversityOC
Eileen Parish
(301) 796-8522

05-29-2003

Indefinite

225-04-4003

Establishes a framework for collaborative research and development and emergency triage response efforts on the subject of Homeland Security.University of CA, Lawrence Livermore National LaboratoryORA
Jeanne Roman
(301) 827-0947

04-14-2004

Indefinite

225-05-6000

To establish terms of collaboration between FDA and BWH to support shared interests and to begin the initiative "The FDA Brigham Elective Program for Residents in the Department of Medicine."Brigham and Women's Hospital

CDRH
Anindita Saha

(301) 796-2537

Mimi Nguyen   

(301) 796-4125

05-09-2006

 

225-05-6001

Establishes collaboration between FDA, Duke University, and Duke University Health System, Inc. in sharing scientific information.Duke University

Duke University Health System, Inc.

CDRH
Annindita Saha

(301) 796-2537

Mimi Nguyen

301-796-4125

09-18-2006

Indefinite

225-07-6001Establishes the terms for collaborative research between the FDA and Stanford University to promote scientific progress in animal and human medicine.Stanford University

CDRH
Anindita Saha
 

(301-796-2537

Mimi Nguyen

301-4125

01-12-201211-11-2017

225-07-8005

To establish terms of collaboration between FDA and Duke, as a part of FDA's Critical Path Initiative. This MOU will serve as the basis of a Public Private Partnership hosted by Duke to systematically modernize the clinical trial process.Duke UniversityOC
Melissa Robb
(301) 827-1516

09-22-2007

Indefinite

225-07-8008 replaces 225-02-8000

To establish collaboration in the areas of advanced scientific training, information exchange and stimulation of cooperative research activities in biotechnology, bioethics, and nanotechnology, particularly with the Institute of NanoBioTechnology.John Hopkins UniversityOC
Eileen Parish
(301) 796-8522

10-11-2007

Indefinite

225-07-8405
Amendment

Establishes terms of collaboration between FDA and the University System of MD to support their shared interest in scientific progress in the diverse disciplines that directly and indirectly affect human and animal health medicine.University System of MDOC
Eileen Parish
(301) 796-8522

07-12-2007

07-11-2017

225-09-0017

Establishes terms of collaboration between FDA and Catholic University (CUA) to supporta variety of programs including research, public outreach, extension activities, cooperative international initiatives, disciplinary training, and exchange of scientists and staff, including sabbaticals, postdoctoral fellowships, and student internships.

Catholic University of America (CUA)OC
Eileen Parish
(301) 796-8522
08-31-200908-30-2014
225-11-0022Establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education research.The Hamner Institutes for Health Sciences' including The Hamner-UNC Institute for Drug Safety  SciencesCDER
Ryan Chatman
(301) 796-2106
12-06-201112-06-2016
225-11-0011To promote scientific progress through exchange of scientific capital in Applied Physics Research in understanding continuous processing and control in micro reactors.University of WashingtonCDER
David Morley
(301) 796-1719
 
04-04-201104-04-2016
225-11-0003To set forth a framework for an alliance between FDA and GUMC.  The MOU is intended to leverage the Parties' combined strengths, resources, and proximity for stimulating innovation in regulatory science, ethics, education, and training within the scope of FDA mission and the broad academic charge of GUMC.Georgetown University Medical CenterOC
Leslie D. Wheelock
(301) 796-8450
 
 02-24-201102-24-2016
225-11-0006Establishes the terms for collaboration to promote shared interests, which can be pursued through a variety of programs including collaborative education researchRegents of the University of California, San FranciscoCDER
Ryan Chatman
(301) 796-2106
02-18-201102-18-2016
225-11-0010To establish a framework for an alliance between FDA-OIP and the O'Neill Institute.Georgetown University Law CenterOIP
Katherine Bond
(301) 796-8318
 
10-19-201110-19-2016
225-11-0012Forms the basis for the initial relations between FDA and the University of Hawaii for sabbaticals, research and scientific education.University of Hawaii at Manoa, Office of Public Health StudiesOMH
Jonca Bull, MD
(301) 796-8000
04-24-12Indefinite
225-11-0015

The Food and Drug Administration (FDA) and the Harvard Medical School, Department of Population Medicine (Harvard), collaborate in promoting scientific progress through exchange of scientific capital in promoting postmarket safety surveillance research.

Harvard Medical SchoolGerald J. Dal Pan, MD, MHS
(301) 796-2380
09-30-201109-29-2016
225-11-0020Establishes the terms for collaboration to promote shared interests, which can be pursued through various programs including collaborative education and researchThe Trustees of Columbia University in the City of New YorkCDER
Mark Lauda
(301) 796-0381
 
10-19-201110-19-2016
225-11-0030Establishes the terms for The United States Food and Drug Administration (FDA) and Duke University (the Parties)to share interests in promoting scientific progress through exchange of scientific capital in an effort to enhance the assessment of safety and efficacy of FDA-regulated products.Duke University

CDER

11-08-201111-08-2016
225-12-0002Establishes the terms for collaboration to promote these shared interests, which can be pursued through a variety of programs including collobrative research, public outreach, extension activities, cooperative international initiatives, and disciplinary training.Austen BioInnovation Institute in AkronCDRH
Michelle McMurry-Heath
(301) 796-7647
12-15-201112-15-2016
225-12-0004Establishes the collaboration between The United States Food and Drug Administration (FDA) and Thomas Jefferson University to share interests in promoting scientific progress through exchange of scientific capital in Clinical Pharmacology Training and Research Program.The Thomas Jefferson UniversityCDER
Ryan Chatman
(301) 796-2106
12-09-201112-09-2016
225-12-0010

Forms the basis betweenThe Food and Drug Administration (FDA) and the Massachusetts Institute of Technology (MIT)to collaborate in promoting scientific progress through exchange of scientific capital in training and research and foresee benefits from the mutual exchange of training and research expertise.

Massachusetts Institute of Technology (MIT)CDER
Nancy Pluhlowski
(301) 796-6660
12-09-201104-15-2017
225-12-0011Forms the basis for the initial relations between FDA and the University of Hawaii, College of Pharmacy for sabbaticals, research and scientific educationUniversity of Hawaii Hilo, College of PharmacyOMH
Jonca Bull, MD
(301) 796-8000
03-30-2012Indefinite
225-12-0018Establishes the terms between the Food and Drug Administration (FDA) and Stanford University (Stanford) to promote scientific progress through exchange of scientific capital in diverse fields of science that affect human and animal health and medicine.Stanford University

Gerald J. Dal Pan, MD MHS(301) 796-2380

05-17-2012Indefinite
225-12-0026Forms the basis for the initial relations between the FDA and The University of Nebraska (UNMC) for sabbaticals, research and scientific education.University of NebraskaOMH
Jonca Bull, MD
(301) 796-8000
06-28-2012 06-28-2017
225-12-0027

Establishes terms of collaboration between U.S. Food and Drug Administration (FDA) and Harvard University, Joslin Diabetes Center to share interests in promoting scientific progress through exchange of scientific capital in epidemiology and research.

Harvard University, Joslin Diabetes Center

Jonca Bull, MD

(301)796-8000

09-14-201209-13-2017
225-12-0029Forms the basis for the initial relations between FDA and Meharry Medical College (Meharry) for sabbaticals, research and scientific education.Meharry Medical CollegeOMH
Jonca Bull, MD
(301) 796-8000
 06-21-2012Indefinite
225-12-0036Establishes terms of collaboration between The United States Food and Drug Administration (FDA) and the University of Medicine and Dentistry of New Jersey (UMDNJ) to share interests in promoting scientific progress through exchange of scientific capital in the clinical pharmacology training and research program. The New Jersey Medical and Health Sciences Education Restructuring Act provides for most schools and units of the University of Medicine and Dentistry of New Jersey, including the School of Health Related Professions, to be transferred to Rutgers, the State University of New Jersey (“Rutgers”) effective July 1, 2013. (Modification 1)University of Medicine and Dentistry of New Jersey (Transferred to Rutgers University)CDER06-19-201206-19-2017

225-93-2001

IL Inst. Tech., participation in short courses, workshops, & training programs in food safety and technology.IL Inst. TechCFSAN
Don Zink
(240) 402-1693

09-03-1993

Indefinite

 225-13-0002Establishes terms of collaboration between FDA and President and Fellows of Harvard College on behalf of the Harvard School of Public HealthHarvard School of Public Health

CDER

NishaBruce

(301) 796-0381

11-14-201211/13/2017
225-13-0020Establishes terms of collaboration between FDA and the University of Hamburg for development of scientific collaborations, outreach and educational initiatives, and intellectual partnerships.University of Hamburg

CFSAN Eric Brown, PhD (240) 402-2020

09-05-2013Indefinite

UMBC

Establishes terms of colla boration between FDA and UMBC to support collaboration on specific projects related to biotechnology process validation, but can serve as a basis for future collaboration in other areas.University of MD Baltimore CountyCDER
Dr. Kurt Brorson
(301) 796-2193

07-25-2003

Indefinite

225-14-0005Establishes terms of collaboration between FDA and the President and Fellows of Harvard College on behalf of Harvard Medical School pursued through a variety of programs including collaborative research, public outreach, extension activities, cooperative international initiatives, and disciplinary training. President and Fellows of Harvard College on behalf of Harvard Medical School

CDRH                            Danica Marinac-Dabic, MD, PhD

(301)796-6689

04-08-201404-07-2019
225-14-0007(OC)This Memorandum of Understanding (MOU) states the mutual intention of the parties to seek opportunities for collaboration and to promote shared interests in various science-based academic initiatives, fellowships, and student internships.
York College of the City University of New York

OMH                              Jonca Bull, MD
(301) 796-8000

02/20/2014Indefinite
225-14-014Promoting scientific progress through exchange of scientific capital in the areas of public health and regulatory research.  Regents of the University of MinnesotaCDER Mark Lauda        301-796-038109/04/201409/03/2019
225-14-8001Establishes terms of collaboration between FDA and the University of Cologne to share interests in promoting scientific progress through knowledge exchange of scientific capital in pharmacology and translational research with regard to characterization of drug transporters.University of CologneCDER, Nisha Bruce,     301-796-260006/30/2014Indefinite
225-15-002
Collaboration to promote these shared interests, which can be pursued through information sharing in regulatory science research, training, sabbaticals, postdoctoral fellowships, and student internships.
University of Massachusetts AmherstORA/WEAC Brian L. Baker 871-856-970109/12/201409/11/2019
 
 
-